-
Regulatory May 8, 2025Report from Annual General Meeting in Vivesto AB
-
Regulatory April 8, 2025Notice of Annual General Meeting in Vivesto AB
-
Non Regulatory April 1, 2025Vivesto reports positive Cantrixil results in an animal hematological cancer model
Interim Report Q2 2025 (in Swedish)
Vivesto published its Q2 report for 2025 on August 12, 2025, at 08.00 am CEST.